BofA flags weak Q3 investment banking fees: one-off warning or sectoral alarm?
BofA flags weak Q3 investment banking fees: one-off warning or sectoral alarm?
Bank of America CEO Brian Moynihan said at the Barclays Global Financial Services Conference that Q3 investment banking fees are tracking $1.6B–$1.8B — a 10%+ decline from $2B in Q3 2025 — while sales and trading revenue is expected to come in flat versus $5.4B last year.
Bank stocks fell across the board on Monday and Tuesday following Moynihan’s warning, amid concerns that it could herald a broader slowdown in IB fees, which are a major profit driver for several banks.
The warning and its context
The culprit: a broad market-wide IB slowdown, slipping financing activity (especially Asia prime brokerage), and the effect of "higher-for-longer" rates on deal pipelines. Bank of America (BAC) shares fell -5.14% to $59.47 by the close, dragging the S&P 500 Banks Index down 2.7%.
This is not a BofA-specific problem. Jefferies’ own data (as of Sep 3) showed IB proxy revenue for eight major global banks already down 15% YoY and 27% from Q2, signalling the stress was evident well before today’s disclosure.
Who else is in the crosshairs?
All prices as of Sep 14, 2026 market close (US banks: 3:59 PM EDT; European banks reflect local closes). Screener values are snapshots and may lag live prices.
| Bank | Price | 1D Chg | 1M Chg | Exposure to Headwinds |
|---|---|---|---|---|
| Bank of America (BAC) | $59.47 | -5.14% | -7.78% | Epicenter — IB -40% Q3-to-date per Jefferies |
| Goldman Sachs (GS) | $988.45 | -3.96% | — | Most resilient: IB only -2% YoY; DCM leader (+41%) |
| JPMorgan (JPM) | $350.13 | -1.71% | — | Relative strength: IB -4%; M&A up 36% |
| Morgan Stanley (MS) | $206.58 | -3.64% | — | Wealth mgmt buffer, but equities trading exposed |
| Citigroup (C) | $136.18 | -1.90% | -2.26% | ECM +65% is a cushion; transformation still in progress |
| Barclays (BARC) | 478.5p | -3.09% | -8.07% | European equities market share slipping vs US peers |
| Deutsche Bank (DBK) | €34.15 | -1.98% | +2.29% | Rates/FICC-heavy; less prime brokerage exposure |
| UBS Group (UBS) | $52.99 | -2.91% | -1.19% | Wealth mgmt dominant; IB restructuring post-CS deal |
The European angle
This is where the structural story gets genuinely interesting. Goldman Sachs flagged in August that European banks’ equities market share has slipped in 4 of the last 6 quarters, with the three largest US players now 2.5x–5x the size of European operations in equities.
- Barclays (BARC) is the European bank most directly exposed — it derives a meaningful chunk of revenue from its investment bank, and the -8.07% monthly slide suggests markets are already pricing in contagion risk. The Barclays conference was the venue where Moynihan delivered his warning.
- Deutsche Bank (DBK) has more of a FICC/rates skew and less prime brokerage reliance — relatively better insulated, and the +2.29% monthly performance reflects that differentiation.
- UBS Group (UBS) is in a different position — its post-Credit Suisse integration has reduced IB ambitions, leaning heavily into wealth management. That is a genuine buffer, though the -2.91% day suggests contagion sentiment.
The one bright spot
Royal Bank of Canada reported record Q3 capital markets net income of CAD $1.5B — up 16% YoY — with investment banking revenue up 23% and global markets up 11%. A reminder that Canadian capital markets, with their resource and commodities deal flow, can move independently of the broader trend.
The macro mechanism
Three interlocking forces are pinching capital markets simultaneously:
- Higher-for-longer rates — Moynihan explicitly flagged rising rates slowing financing demand; advisory pipelines stay "solid" but cannot fully compensate
- Asia prime brokerage deleveraging — International clients pulling risk off the table post-Liberation Day anniversary volatility
- Tough base effects — Q2 2026 was elevated by Liberation Day hedging flows; Q3 is lapping that period
Goldman Sachs (GS) and JPMorgan (JPM) remain the relative safe harbors — their breadth across M&A advisory (GS +25%, JPM +36% annualized) and dominant ECM positions give them shock absorbers that mid-tier IB players simply lack.